language

Product Center

Establishing a platform for the development of shark-derived single-domain antibody therapeutics, injecting new momentum into global health initiatives.

Home page

Functional food

Pharmaceutical intermediate

Animal Nutrition

CDMO

Pharmaceutical intermediate

Thymosin

An intermediate consisting of a low-molecular-weight peptide mixture derived from the animal thymus, serving as a core raw material for immunomodulatory drugs, with a stable proportion of active constituents and compliance with pharmaceutical manufacturing requirements.

Pharmaceutical intermediate

Beef liver extract

A natural bovine‑derived liver active extract intermediate, rich in amino acids, small‑molecule bioactive peptides, and coenzyme components, suitable for the research, development, and production of hepatoprotective and blood‑tonifying pharmaceuticals.

Pharmaceutical intermediate

Cerebroprotein hydrolysate

The intermediate of an animal brain‑derived peptide mixture, prepared via enzymatic hydrolysis, is widely used in the development of neurological therapeutics; it features a high content of small‑molecule peptides and exhibits excellent batch‑to‑batch stability.

Pharmaceutical intermediate

Insulin (porcine)

Porcine-derived natural insulin intermediates serve as the foundational raw material for the research and development and production of diabetes‑related therapeutics. Their primary structure exhibits high homology to human insulin, and their purity meets pharmaceutical standards.

Pharmaceutical intermediate

Bromelain

A natural protease intermediate derived from pineapple exhibits anti-inflammatory and anti-edema pharmacological activities, making it suitable as a raw material for anti-inflammatory drugs and as a tool enzyme in biopharmaceutical applications. The product meets activity specifications and features low residual impurities.

Pharmaceutical intermediate

Rennet (sheep)

A natural protease intermediate derived from sheep, primarily used in the research and development and manufacturing of gastrointestinal drugs, with stable enzymatic activity and high process compatibility.

Pharmaceutical intermediate

Heparin and Heparinoids

A core intermediate for anticoagulant drugs, widely used in the manufacture of therapeutics for thrombotic disorders and anticoagulant excipients. It is available in various molecular weight grades, with impurity levels compliant with pharmacopoeial standards.

CDMO

Chondroitinase AC

Chondroitinase AC is a hydrolase. It specifically degrades CS A (4‑sulfated chondroitin sulfate) and CS C (6‑sulfated chondroitin sulfate), but does not degrade CS B (dermatan sulfate). This enzyme is recombinantly expressed in E. coli.

CDMO

Streptokinase

Streptokinase is a proteolytic enzyme secreted by β-hemolytic streptococci, with a molecular weight of approximately 47 kDa and composed of 414 amino acids. It exerts its thrombolytic effect by activating plasminogen to convert it into plasmin. Recombinant streptokinase is a recombinant protein drug used to dissolve blood clots, primarily indicated for the treatment of acute myocardial infarction and other thrombotic disorders. This product is expressed recombinantly in E. coli.

< 1 2 3 4 > proceed page

Committed to providing high-quality bioactive solutions for human health, animal nutrition, and agricultural biotechnology.

Shaoxing Jawin Biotechnology Co., Ltd.

Phone:0575-82161872

Email:info@jawinbio.com

Address: 3rd Floor, Building 3, No. 36 Kangyang Avenue, Hangzhou Bay Economic and Technological Development Zone, Shangyu District, Shaoxing City, Zhejiang Province

Website Development: China Enterprise Dynamics, Shaoxing

Telephone：0575-82161872

Email box：info@jawinbio.com

Sorry, there is currently no content in this section.

You can view other sections.

Business license

Business License